30 January 2018 | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic | Clissold, RL; Fulford, J; Hudson, M; et al. |
8 November 2019 | Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: Lessons from a 5-year pediatric Swedish national cohort study | Carlsson, A; Shepherd, M; Ellard, S; et al. |
12 November 2020 | Long-term follow-up of glycemic and neurological outcomes in an international series of patients with sulfonylurea-treated ABCC8 permanent neonatal diabetes | Bowman, P; Mathews, F; Barbetti, F; et al. |
12 June 2020 | Non-invasive fetal genotyping by droplet digital PCR to identify maternally-inherited monogenic diabetes variants | Caswell, R; Snowsill, T; Houghton, J; et al. |
9 November 2020 | YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress | De Franco, E; Lytrivi, M; Ibrahim, H; et al. |
8 October 2020 | Type 1 Diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta-cells | Johnson, MB; Patel, KA; De Franco, E; et al. |
16 January 2013 | Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
6 December 2012 | GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
12 June 2018 | The Common HNF1A Variant I27L is a Modifier of Age at Diabetes Diagnosis in HNF1A-MODY Individuals. | Locke, JM; Saint-Martin, C; Laver, TW; et al. |
18 September 2018 | A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | Shepherd, MH; Shields, BM; Hudson, M; et al. |